comparemela.com

Latest Breaking News On - Global antibiotic research - Page 11 : comparemela.com

Breakthrough Antibiotic Offers Hope Against Drug-Resistant Gonorrhea

Discover the latest breakthrough in STI treatment as zoliflodacin, a new antibiotic, shows effectiveness against drug-resistant gonorrhea in clinical trials.

United statesJeffrey klausnerJeanne marrazzoDevelopment partnershipGlobal antibiotic researchNational institute of allergyKeck school of medicineHealth officials warnNational cancer institute on unsplashWorld health organizationCenters for diseaseDrug administrationNational cancer instituteTrials validate efficacyInnoviva specialty therapeuticsKeck school

Oral Zoliflodacin Noninferior to Standard of Care for Uncomplicated Gonorrhea

Treatment with oral zoliflodacin was found to be noninferior to ceftriaxone and oral azithromycin for the treatment of gonorrhea infection.

Drug administrationGlobal antibiotic research development partnershipUniversity of alabamaGlobal antibiotic researchDevelopment partnershipInnoviva specialtyProtocol chairEmeritus professor

New antibiotic shows promise for drug-resistant gonorrhea – NBC Los Angeles

Gonorrhea, the second most common STI in the U.S., has developed resistance to all antibiotics used to treat it, except for one last recommended therapy.

Jeffrey klausnerKeck school of medicineGlobal antibiotic research development partnershipGlobal antibiotic researchDevelopment partnershipInnoviva specialtyKeck schoolHealth amp science

New antibiotic shows promise for drug-resistant gonorrhea – NBC10 Philadelphia

Gonorrhea, the second most common STI in the U.S., has developed resistance to all antibiotics used to treat it, except for one last recommended therapy.

Jeffrey klausnerGlobal antibiotic research development partnershipKeck school of medicineGlobal antibiotic researchDevelopment partnershipInnoviva specialtyKeck schoolHealth amp science

New antibiotic shows promise for drug-resistant gonorrhea – NBC 5 Dallas-Fort Worth

Gonorrhea, the second most common STI in the U.S., has developed resistance to all antibiotics used to treat it, except for one last recommended therapy.

Jeffrey klausnerGlobal antibiotic research development partnershipKeck school of medicineGlobal antibiotic researchDevelopment partnershipInnoviva specialtyKeck schoolHealth amp science

vimarsana © 2020. All Rights Reserved.